| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Mtr3g3420 | ATGGCAGAGGAATCTCCAAAGATAGCCACAACTCAAGAGACAGTGCCTCTTGCTGAGGAGCAAGTGGTGGTCACTCAAAAAACAGAATCCCCTGTTCCAGCTGACAAAGAATCTGATCAGCCCAAGCCCAACCCAGAGCCCGTTGAAAACAACACTACTGAGACGGAGGAGGTATCAAAGCCCAGTGGTGATGACAAAATTCCAGAGTCTGGTTCTTTCAAAGAAGAGAGTACTATTGTTGGTGAGCTACCTGAAGCTGAGAAGAAAGCACTTGCAGAGCTGAAACAGCTTATTCAAGAAGCACTTAACAAACATGAATTCTCTGCACCAGCTTCAACTACTCCAAGCCCAGTTAAAGAACAAAAGCCCGAGCCCACACCAGAAGCACCTGCTGAAGAGACCAACAAGAAAGATGAGCAGGTTTCTGAAACAGAATCTGTTGTTGCTGTTACTACTGCAGATGATGACGTATCAACAACACCACCACCACCACCAACTGAAGCTGAAGCTGAAGCTGAACAACCAAAAGAAGAAGTAGAAAAGAAAGAAACAGAGGTTGCTGCTTCTTCTGTAGATGAAGATGGAGCGAAAACAGTTGAAGCAATTGAAGAATCTGTTGTAGCTGTAGCTTCATCAGTTCCAGAGGAACCAAAGGTGGTGGAAGCTTCTTCACCGGAACAACAACAACCAGAAGAGGTTTCAATATGGGGGATACCACTCCTCGCAGACGATAGAACCGACGTGATTCTGTTGAAGTTTCTCCGAGCCAGAGACTTCAAAGTGAAAGAAGCATTCACAATGATCAAGAACACTATCCGTTGGAGAAAAGAGTTCAAAATCGAAGAGTTGTTATTAGATGAAAACTTAGGTGATGAATATTTAGAGAAAACTGTTTACATGCATGGCTATGATAAAGAAGGACACCCTGTTTGTTATAATATTTATGGAGAGTTTGATAACAAGGAGGTTTATAAGAAAACATTTTCAGATGAAGAGAAGAGAGAAAGATTCTTGAAATGGAGAATTCTGGTCTTGGAGAAGAGTATAAGGAAATTGGATTTTACCCCTGGTGGTATATGCACCATTGTTCAGGTTAATGATCTTAAGAATTCTCCTGGACCTACCAAATGGGAGCTTAGACAAGCTACCAAACAAGCCCTTCAATTGCTTCAAGATAATTATCCTGAATTTGTAGCCAAACAGGTGTTTATCAATGTGCCATGGTGGTACTTAGCTGTGAACAGAATGATAAGTCCTTTTCTTACACAAAGAACAAAAAGCAAGTTTGTTTTTGCTGGGCCTTCCAAATCAGCTGAAACTCTTCTAAGTTACATAGCTCCGGAGCAACTTTCAGTCAAATATGGTGGACTAAGCAAAGATGGTGAATTTGGAATTACTGATGCTGTTACAGAAATTACAGTGAGGCCTGCGGCAAAACACATCGTGGAATTTCCAGTTACTGAGAACTGTTTACTCTCTTGGGAGCTAAGAGTAATTGGGTGGGACATAAGCTATGGTGCAGAGTTTGTACCAAGTTCAGAAGGAAGCTACACTGTGATAATCCAGAAGACTAGAAAAATTGCTTCATCAGAAGAACCAGTGCTTTGTAACAACTACAAAATTGGTGAACCTGGGAAAGTTGTTCTCACCATTGACAATTCAAGCTCTAAGAAGAAGAAGCTCTTGTACCGCTTGAAGACCAAGCCTTCAACTTCTGATTAA | 1722 | 0.4152 | MAEESPKIATTQETVPLAEEQVVVTQKTESPVPADKESDQPKPNPEPVENNTTETEEVSKPSGDDKIPESGSFKEESTIVGELPEAEKKALAELKQLIQEALNKHEFSAPASTTPSPVKEQKPEPTPEAPAEETNKKDEQVSETESVVAVTTADDDVSTTPPPPPTEAEAEAEQPKEEVEKKETEVAASSVDEDGAKTVEAIEESVVAVASSVPEEPKVVEASSPEQQQPEEVSIWGIPLLADDRTDVILLKFLRARDFKVKEAFTMIKNTIRWRKEFKIEELLLDENLGDEYLEKTVYMHGYDKEGHPVCYNIYGEFDNKEVYKKTFSDEEKRERFLKWRILVLEKSIRKLDFTPGGICTIVQVNDLKNSPGPTKWELRQATKQALQLLQDNYPEFVAKQVFINVPWWYLAVNRMISPFLTQRTKSKFVFAGPSKSAETLLSYIAPEQLSVKYGGLSKDGEFGITDAVTEITVRPAAKHIVEFPVTENCLLSWELRVIGWDISYGAEFVPSSEGSYTVIIQKTRKIASSEEPVLCNNYKIGEPGKVVLTIDNSSSKKKKLLYRLKTKPSTSD* | 574 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 103 | 197 | - | - | |
| Mtr3g3420 | 573 | Gene3D | GOLD domain | 472 | 567 | - | - | |
| Mtr3g3420 | 573 | SUPERFAMILY | Supernatant protein factor (SPF), C-terminal domain | 468 | 567 | IPR036598 | - | |
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 170 | 197 | - | - | |
| Mtr3g3420 | 573 | Pfam | CRAL/TRIO domain | 297 | 456 | IPR001251 | - | |
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 7 | 28 | - | - | |
| Mtr3g3420 | 573 | SUPERFAMILY | CRAL/TRIO domain | 297 | 459 | IPR036865 | - | |
| Mtr3g3420 | 573 | SMART | sec14_4 | 292 | 459 | IPR001251 | - | |
| Mtr3g3420 | 573 | CDD | SEC14 | 294 | 457 | IPR001251 | - | |
| Mtr3g3420 | 573 | Pfam | CRAL/TRIO, N-terminal domain | 230 | 270 | IPR011074 | - | |
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 125 | 143 | - | - | |
| Mtr3g3420 | 573 | Gene3D | - | 165 | 471 | IPR036865 | - | |
| Mtr3g3420 | 573 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 286 | 462 | IPR001251 | - | |
| Mtr3g3420 | 573 | PANTHER | PATELLIN-3 PROTEIN | 22 | 573 | - | - | |
| Mtr3g3420 | 573 | PRINTS | Cellular retinaldehyde-binding protein signature | 249 | 271 | - | - | |
| Mtr3g3420 | 573 | PRINTS | Cellular retinaldehyde-binding protein signature | 414 | 433 | - | - | |
| Mtr3g3420 | 573 | PANTHER | PATELLIN-1 | 22 | 573 | IPR044834 | GO:0008289 | |
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 1 | 81 | - | - | |
| Mtr3g3420 | 573 | SMART | CRAL_TRIO_N_2 | 246 | 271 | IPR011074 | - | |
| Mtr3g3420 | 573 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 72 | 286 | IPR036273 | - | |
| Mtr3g3420 | 573 | MobiDBLite | consensus disorder prediction | 58 | 72 | - | - | |
| Mtr3g3420 | 573 | ProSiteProfiles | GOLD domain profile. | 466 | 567 | IPR009038 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Mtr3g3420 | Mtr-Chr3 | 48086369 | 48089389 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Mtr3g3420 | 250 | 436 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 30.151 | 9.15e-11 | 61.2 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Mtr3g3420 | - | - | gmx:100805585 | 712.99 |